Amgen, one of the world’s leading biotechnology companies, plans to invest $365 million to build a new manufacturing facility in New Albany, Ohio. The project is expected to create 400 jobs.
Greenfield construction of the new 270,000-square-foot facility is expected to begin in the fall of 2021. Amgen will invest in land acquisition, building construction and manufacturing equipment.
“We are proud of our track record of providing a reliable supply of high-quality medicines for patients around the world,” said Amgen Executive Vice President of Operations Esteban Santos. “We are adding this additional assembly and packaging plant to our global supply chain network to support the anticipated growth in demand for Amgen medicines. We plan to include some of our most advanced digital automation technologies in this new location as we partner with the thriving business community of the Columbus Region to further expand biotechnology regionally.”
According to city officials, the Amgen facility in New Albany will be built to exacting environmental standards, consistent with the company’s goal of achieving carbon neutrality by 2027. The facility also will support Amgen’s participation as a founding member of OneTen, a coalition of many of the world’s largest, best-known companies that aims collectively to hire one million Black Americans into well-paying jobs over the next ten years, with a specific focus on those without a four-year college degree.
“Amgen is a global pioneer on the front lines of restoring health and providing therapies for those fighting serious illnesses such as cancer,” said Ohio Governor Mike DeWine. “Attracting a biotechnology leader to the Columbus Region was a collaborative effort between the Ohio Development Services Agency, JobsOhio and its partners, and we look forward to working with Amgen as it improves healthcare throughout the world with talent from Ohio.”
The location will feature Amgen’s most advanced assembly and final product packaging capabilities for medicines to be distributed in the U.S.